The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma

Cytochrome P2C (CYP2C) subfamily members (CYP2C8,CYP2C9,CYP2C18, and CYP2C19) are known to participate in clinical drug metabolism. However, the association between CYP2C subfamily members and hepatocellular carcinoma (HCC) remains unclear. This study investigated the prognostic value of CYP2C subfa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Wang, Xiangkun, Yu, Tingdong, Liao, Xiwen, Yang, Chengkun, Han, Chuangye, Zhu, Guangzhi, Huang, Ketuan, Yu, Long, Qin, Wei, Su, Hao, Liu, Xiaoguang, Peng, Tao
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5911570/
https://ncbi.nlm.nih.gov/pubmed/29479826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1299
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky